LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Bladder Cells Use Exocytosis to Fight Urinary Tract Infections

By LabMedica International staff writers
Posted on 02 Aug 2016
Image: Multiple bacilli (rod-shaped bacteria, here shown as black and bean-shaped) shown between white blood cells in urinary microscopy. These changes are indicative of a urinary tract infection (Photo courtesy of Wikimedia Commons).
Image: Multiple bacilli (rod-shaped bacteria, here shown as black and bean-shaped) shown between white blood cells in urinary microscopy. These changes are indicative of a urinary tract infection (Photo courtesy of Wikimedia Commons).
A team of molecular microbiologists has identified a method used by the cells lining the bladder to protect themselves against urinary tract pathogens by packaging bacteria into vesicles that are expelled from the cytoplasm.

Investigators at Duke University (Durham, NC, USA) and colleagues at the National University of Singapore (Singapore) worked with mice and cultured human bladder cells to study the mechanism used by the bladder to fight off urinary tract infection (UTI).

They reported in the July 19, 2016, online edition of the journal Immunity that infected bladder epithelial cells (BECs) mobilized the exocyst complex, a powerful exporter of subcellular vesicles, to rapidly expel intracellular bacteria back for clearance. In this process, called exocytosis, membrane-bound secretory vesicles are carried to the cell membrane, and their contents (water-soluble molecules such as proteins) are secreted into the extracellular environment. This secretion is possible because the vesicle transiently fuses with the outer cell membrane.

While the investigators had previously reported that expulsion of harmful bacteria was partially mediated by lysosomes, cellular structures that ordinarily degrade waste, this was the first report of bacterial expulsion via exocytosis. In addition, this process was linked to action of the compound Forskolin, which has a strong impact on urinary tract infections, even in the absence of antibiotics. Forskolin activates the enzyme adenylyl cyclase and increases intracellular levels of cAMP, an important second messenger necessary for the proper biological response of cells to hormones and other extracellular signals.

"There is growing interest in identifying new ways to fight UTIs, as bacteria are becoming increasingly resistant to antibiotics," said senior author Dr. Soman Abraham, professor of pathology, immunology, microbiology, and molecular genetics at Duke University. "In the past, we identified a plant extract called Forskolin, which has a strong impact on UTIs, even in the absence of antibiotics. Unfortunately, we did not understand how it worked. These latest findings could provide the key to how the herb effectively combats UTIs. If this link can be established, we could help advance the case for testing the herb and other similar-acting drugs as a potential new treatment for UTIs."

Related Links:
Duke University
National University of Singapore
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more